Key result
Management of acute coronary syndromes in 2002-2005 compared to 1997-1998 showed increased use of evidence-based therapies and decreased hospital mortality (7.7% vs 13%, P<0.01).
Why the study?
Does increased utilization of evidence-based therapies improve in-hospital mortality in patients with acute coronary syndromes?
Observational (n=1,025)
No
Does increased utilization of evidence-based therapies improve in-hospital mortality in patients with acute coronary syndromes?
Absolute Event Rate: 7.7% vs 13%
p-value: p=<.01
Increased adherence to evidence-based therapies for acute coronary syndromes in a developing country setting was associated with a significant reduction in hospital mortality from 13% to 7.7%.
OBJECTIVES: Data on acute coronary syndromes (ACS) in developing countries is scarce. In this report, we analyze the temporal trends in the management and outcomes of a large series of ACS patients hospitalized at the American University of Beirut Medical Center (AUBMC), a tertiary referral university hospital located in a middle income Middle Eastern developing country. METHODS: A total of 1025 consecutive patients hospitalized and discharged with the diagnosis of ACS were enrolled between 2002 and 2005. The utilization of evidence-based therapies and in-hospital outcomes were determined. RESULTS: The study enrolled 228 patients (22%) with ST-elevation myocardial infarction (STEMI), 275 patients (27%) with non-ST-elevation myocardial infarction (NSTEMI), and 522 patients (51%) with unstable angina. The STEMI group was younger and had a higher percentage of men. The utilization rates of coronary angiography and percutaneous coronary intervention (PCI) were highest in the STEMI group. Comparison to earlier ACS data (1997-1998) from the same hospital, showed an increase in the utilization of reperfusion therapy, coronary angioplasty, bypass surgery, aspirin, beta-blockers, angiotensin-converting enzymes (ACE), angiotensin receptor blockers (ARB), and statins over the past decade (P < .05). This was associated with a significant decrease in hospital mortality (13%-7.7%, P < .01). CONCLUSIONS: This study analyzes one of the largest series of ACS patients reported from a single center in a developing country. The utilization of evidence-based therapies in the management of ACS at AUBMC has improved significantly over the past decade with an associated decrease in hospital mortality.
No takes yet. Share an insight, caveat, or question.
Abdallah et al. (2009) conducted an observational in Acute coronary syndromes (n=1,025). Contemporary management (2002-2005) vs. Historical management (1997-1998) was evaluated on Hospital mortality (p=<.01). Management of acute coronary syndromes in 2002-2005 compared to 1997-1998 showed increased use of evidence-based therapies and decreased hospital mortality (7.7% vs 13%, P<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: